• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Catherine Pearce, Australia

    Catherine Pearce, Australia

  • Steve Lufkin, USA

    Steve Lufkin, USA
    IMG_3993

  • Daniela Maria Daverio, Argentina

    Daniela Maria Daverio, Argentina

  • Bob Simonds, USA

    Bob Simonds, USA

  • Jean Waters, UK

    Jean Waters, UK

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • David Bishop, UK

    David Bishop, UK

  • Jeff Sutherland, Canada

    Jeff Sutherland, Canada
    jspic

  • Jon Newsome, USA

    Jon Newsome, USA

  • Alex, Argentina

    Alex, Argentina

  • Rob Tison, USA

    Rob Tison, USA

  • Wiebke Braach, Germany

    Wiebke Braach, Germany

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Liong Ting Ngu, Malaysia

    Liong Ting Ngu, Malaysia

  • Ali Var, Turkey

    Ali Var, Turkey

  • Motoko Ogasawara, Japan

    Motoko Ogasawara, Japan

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • H. Todd Kelly, USA

    H. Todd Kelly, USA

  • Ann Nicol, USA

    Ann Nicol, USA

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Antonio Ventriglia, Belgium

    Antonio Ventriglia, Belgium

  • Mauril Bélanger, Canada

    Mauril Bélanger, Canada

  • Margarita Pizarro, Argentina

    Margarita Pizarro, Argentina

  • João Marcos Andrietta, Brazil

    João Marcos Andrietta, Brazil

  • Steve

    Steve

  • Ana Lilia Rodriguez, Mexico

    Ana Lilia Rodriguez, Mexico

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Mike Small, UK

    Mike Small, UK

  • Liam Dwyer, England

    Liam Dwyer, England

  • Steven Gallagher, Canada

    Steven Gallagher, Canada

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • David Hall, USA

    David Hall, USA

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Daniel Hare, USA

    Daniel Hare, USA

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Rosie Riley, USA

    Rosie Riley, USA

  • Kris Van Reusel, Belgium

    Kris Van Reusel, Belgium

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Anita Forte, USA

    Anita Forte, USA

  • Glen Elison, USA

    Glen Elison, USA

  • Ian Gale, Australia

    Ian Gale, Australia

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Hollister

    Hollister
    hollister

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login